hsa-mir-95: Hsa-mir-95 is one of the six miRNAs that showed significant differential expression in both periapical and pulp tissues [PMC9987318]. Among these miRNAs, hsa-mir-95, hsa-miR-375, and hsa-miR-503 were strongly associated with type 2 diabetes mellitus (T2DM) [PMC10126023]. In a study comparing kidney tissues of healthy individuals with those of patients with diabetic nephropathy (DN), hsa-mir-95 was found to be differentially expressed [PMC8616647]. Additionally, hsa-mir-95 was also differentially expressed in a study comparing pancreatic neuroendocrine tumors (PNETs) with pancreatic ductal adenocarcinomas (PDACs) [PMC7352720]. It is suggested that extracellular vesicles containing miRNAs associated with proliferation or apoptosis inhibition, such as hsa-mir-95 or has-miR-106a-5p, may have regenerative potential [PMC10126023]. On the other hand, during control myogenesis, 12 miRNAs were found to be differentially expressed, including hsa-mir-95 as one of the up-regulated ones [PMC4186784]. Overall, these findings highlight the potential role of hsa-mir-95 in various biological processes and diseases.